Signify Premium Insight: General Catalyst: An Appetite for Disruption
Published: November 28, 2022
It has been a whirlwind last 18 months for US venture capital (VC) giant General Catalyst (GC). Having unleashed $2.3B-plus in capital through its Health Assurance Fund since last year – becoming the world’s top digital health investor in the process – it then announced, on 15 November 2022, partnerships with 15 major health system networks.
GC was typically forthright in announcing the development. It insists the new partners will offer a “cross-pollination of learnings that can be a powerful antidote to today’s broken and siloed system.”
This is a clear reference to current interoperability challenges and the march towards value-based care (VBC), especially in the US. Given the growth potential in these areas, allied with GC’s bold approach (and financial clout), the company is primed to be the healthcare disruptor, influencer and enabler-in-chief of our times.